APYX Apyx Medical Corp
Nasdaq · SEC CIK 719135 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 83 since 2021-08-11, latest 2026-07-02 17:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Roman Shawn David | COO | — | — |
| Vizirgianakis Stavros G. | Dir | — | — |
| Waldman Lawrence | Dir | — | — |
| CITRONOWICZ MOSHE | SVP | — | — |
Transactions 27
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-07-02 17:00 | 2026-06-30 | APYX | Waldman Lawrence | Dir | M - OptEx | $1.88 | +12.0K | 17.3K | +225% | +$22.6K |
| DI | 2026-07-02 17:00 | 2026-06-30 | APYX | Waldman Lawrence | Dir | F - Tax | $4.49 | -5,024 | 12.3K | -29% | -$22.6K |
| DI | 2026-06-17 17:15 | 2026-06-15 | APYX | Roman Shawn David | COO | M - OptEx | $3.23 | +15.0K | 15.0K | New | +$48.5K |
| DI | 2026-06-17 17:15 | 2026-06-15 | APYX | Roman Shawn David | COO | F - Tax | $4.60 | -10.5K | 16.5K | -39% | -$48.5K |
| 2026-06-15 19:00 | 2026-06-11 | APYX | Vizirgianakis Stavros G. | Dir | A - Grant | $0.00 | +450.0K | 2.20M | +26% | $0 | |
| D | 2026-03-17 | 2026-03-15 | APYX | CITRONOWICZ MOSHE | SVP | M - OptEx | $1.80 | +37.0K | 493.5K | +8% | +$66.6K |
| DI | 2026-01-29 | 2026-01-27 | APYX | Roman Shawn David | COO | M - OptEx | $1.80 | +12.0K | 12.0K | New | +$21.6K |
| A | 2025-03-03 | 2024-08-13 | APYX | HILL MATTHEW C | CFO | P - Purchase | $1.13 | +6,000 | 8,500 | +240% | +$6,780 |
| 2024-08-13 | 2024-08-13 | APYX | HILL MATTHEW C | CFO | P - Purchase | $1.13 | +5,336 | 7,836 | +213% | +$6,030 | |
| 2023-12-14 | 2023-12-12 | APYX | HILL MATTHEW C | CFO | P - Purchase | $2.19 | +2,500 | 2,500 | New | +$5,475 | |
| 2023-11-15 | 2023-11-14 | APYX | Goodwin Charles D. II | CEO, Dir | P - Purchase | $1.57 | +50.0K | 90.0K | +125% | +$78.5K | |
| DI | 2023-07-19 | 2023-07-12 | APYX | Waldman Lawrence | Dir | M - OptEx | $2.97 | +5,338 | 5,338 | New | +$15.9K |
| DA | 2023-06-29 | 2023-06-26 | APYX | Hornsby Todd | EVP | S - Sale+OE | $7.56 | -15.0K | 0 | -100% | -$113.4K |
| DA | 2023-06-29 | 2023-06-26 | APYX | Hornsby Todd | EVP | M - OptEx | $1.77 | +15.0K | 15.0K | New | +$26.6K |
| D | 2023-06-28 | 2023-06-26 | APYX | Hornsby Todd | EVP | M - OptEx | $1.77 | +15.0K | 15.0K | New | +$26.6K |
| D | 2023-06-28 | 2023-06-26 | APYX | Hornsby Todd | EVP | S - Sale+OE | $7.56 | -15.0K | 40 | -100% | -$113.4K |
| D | 2023-06-09 | 2023-06-06 | APYX | Geraghty Michael | Dir | M - OptEx | $2.79 | +10.0K | 27.5K | +57% | +$27.9K |
| D | 2023-03-22 | 2022-01-07 | APYX | Swandal Craig A. | Dir | M - OptEx | $9.42 | +7,173 | 60.2K | +14% | +$67.6K |
| M | 2022-08-31 | 2022-08-29 | APYX | Goodwin Charles D. II | CEO, Dir | P - Purchase | $5.96 | +11.8K | 30.2K | +64% | +$70.1K |
| D | 2022-07-12 | 2022-07-11 | APYX | CITRONOWICZ MOSHE | SVP. of Ops | M - OptEx | $2.54 | +30.0K | 456.5K | +7% | +$76.2K |
| D | 2022-07-11 | 2022-07-11 | APYX | Waldman Lawrence | Dir | M - OptEx | $2.54 | +24.0K | 37.6K | +177% | +$61.0K |
| D | 2022-07-11 | 2022-07-06 | APYX | Geraghty Michael | Dir | M - OptEx | $2.54 | +4,000 | 17.5K | +30% | +$10.2K |
| D | 2022-07-11 | 2022-07-05 | APYX | MAKRIDES ANDREW | Dir | M - OptEx | $2.54 | +30.0K | 638.0K | +5% | +$76.2K |
| D | 2022-07-11 | 2022-07-05 | APYX | MAKRIDES ANDREW | Dir | F - Tax | $6.14 | -13.6K | 624.4K | -2% | -$83.4K |
| D | 2022-05-23 | 2022-05-19 | APYX | Waldman Lawrence | Dir | M - OptEx | $2.79 | +8,000 | 13.6K | +144% | +$22.3K |
| D | 2022-05-19 | 2022-05-11 | APYX | Geraghty Michael | Dir | M - OptEx | $2.79 | +6,000 | 13.5K | +80% | +$16.7K |
| D | 2022-03-22 | 2022-03-21 | APYX | Swandal Craig A. | Dir | M - OptEx | $4.98 | +17.0K | 17.0K | New | +$84.7K |
Purchase Sale Sale after option exercise All abbreviations